Anna Gayà

3.1k total citations
51 papers, 2.1k citations indexed

About

Anna Gayà is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Anna Gayà has authored 51 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Immunology, 20 papers in Hematology and 12 papers in Genetics. Recurrent topics in Anna Gayà's work include Complement system in diseases (22 papers), Renal Diseases and Glomerulopathies (10 papers) and Blood groups and transfusion (9 papers). Anna Gayà is often cited by papers focused on Complement system in diseases (22 papers), Renal Diseases and Glomerulopathies (10 papers) and Blood groups and transfusion (9 papers). Anna Gayà collaborates with scholars based in Spain, United Kingdom and United States. Anna Gayà's co-authors include Alfons Navarro, Emili Montserrat, Mariano Monzó, Antonio M. Risitano, Antonio Martı́nez, Bernat Gel, Peter Hillmen, Jörg Schubert, Russell P. Rother and Aina Pons and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Anna Gayà

50 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Gayà Spain	21	1.1k	655	525	506	495	51	2.1k
Jens Panse Germany	25	917 0.9×	705 1.1×	244 0.5×	407 0.8×	360 0.7×	154	2.2k
Anita Hill United Kingdom	23	2.7k 2.5×	2.2k 3.3×	1.4k 2.6×	1.2k 2.4×	178 0.4×	54	4.2k
Spero R. Cataland United States	33	2.7k 2.5×	1.7k 2.6×	1.4k 2.7×	1.0k 2.1×	415 0.8×	113	3.7k
Taimur Sher United States	24	313 0.3×	574 0.9×	69 0.1×	362 0.7×	795 1.6×	124	2.1k
Daniel J. Birmingham United States	28	1.4k 1.3×	593 0.9×	547 1.0×	156 0.3×	341 0.7×	66	2.4k
Britta Höchsmann Germany	21	988 0.9×	838 1.3×	486 0.9×	429 0.8×	109 0.2×	65	1.6k
Seah H. Lim United States	29	1.4k 1.3×	960 1.5×	51 0.1×	381 0.8×	1.2k 2.4×	131	2.9k
Bruno Fattizzo Italy	24	525 0.5×	1.4k 2.1×	109 0.2×	647 1.3×	173 0.3×	147	2.3k
Anne Huynh France	28	359 0.3×	1.6k 2.5×	93 0.2×	499 1.0×	625 1.3×	130	2.7k
Diane van der Woude Netherlands	32	1.1k 1.0×	463 0.7×	46 0.1×	343 0.7×	606 1.2×	85	4.1k

Countries citing papers authored by Anna Gayà

Since Specialization

Citations

This map shows the geographic impact of Anna Gayà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Gayà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Gayà more than expected).

Fields of papers citing papers by Anna Gayà

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Gayà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Gayà. The network helps show where Anna Gayà may publish in the future.

Co-authorship network of co-authors of Anna Gayà

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Gayà. A scholar is included among the top collaborators of Anna Gayà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Gayà. Anna Gayà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Piatek, Caroline, Jong Wook Lee, Morag Griffin, et al.. (2024). Danicopan As Add-on Therapy to Ravulizumab or Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria: Long-Term Patient-Reported Outcomes from the Phase 3 ALPHA Trial. Blood. 144(Supplement 1). 2692–2692. 1 indexed citations

Röth, Alexander, Guangsheng He, Andrés Brodsky, et al.. (2024). Phase III Randomized COMMODORE 2 Trial: 2-Year Efficacy and Safety of Crovalimab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Naive to Complement Inhibition. Blood. 144(Supplement 1). 2687–2687.

Latour, Régis Peffault de, Jeff Szer, Austin Kulasekararaj, et al.. (2023). PB2064: THE COMPLETE STUDY: A SINGLE ARM, MULTICENTER OBSERVATIONAL STUDY TO EVALUATE EFFECTIVENESS OF PEGCETACOPLAN UNDER REAL WORLD CONDITIONS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH). HemaSphere. 7(S3). e36410cc–e36410cc. 2 indexed citations

Peipert, John Devin, Austin Kulasekararaj, Anna Gayà, et al.. (2020). Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria. PLoS ONE. 15(9). e0237497–e0237497. 34 indexed citations

Camprubí, Daniel, Anna Gayà, María Ángeles Marcos, et al.. (2020). Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir. International Journal of Infectious Diseases. 104. 379–381. 33 indexed citations

Villegas, Ana, Beatriz Arrizabalaga, Santiago Bonanad, et al.. (2016). Consenso español para el diagnóstico y tratamiento de la hemoglobinuria paroxística nocturna. Medicina Clínica. 146(6). 278.e1–278.e7. 12 indexed citations

Navarro, Alfons, Carmen Muñoz, Anna Gayà, et al.. (2013). MiR-SNPs as Markers of Toxicity and Clinical Outcome in Hodgkin Lymphoma Patients. PLoS ONE. 8(5). e64716–e64716. 18 indexed citations

Díaz, Tania, Alfons Navarro, Gerardo Ferrer, et al.. (2011). Lestaurtinib Inhibition of the JAK/STAT Signaling Pathway in Hodgkin Lymphoma Inhibits Proliferation and Induces Apoptosis. PLoS ONE. 6(4). e18856–e18856. 62 indexed citations

Martínez‐Trillos, Alejandra, Anna Gayà, Margherita Maffioli, et al.. (2010). Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients. Annals of Hematology. 89(12). 1233–1237. 108 indexed citations

10.

Urbano-Ispizúa, Álvaro, Anna Gayà, Enrique Colado, et al.. (2010). Diagnóstico y tratamiento de la hemoglobinuria paroxística nocturna. Medicina Clínica. 136(3). 121–127. 6 indexed citations

11.

Maffioli, Margherita, Mireia Camós, Anna Gayà, et al.. (2010). Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemia. Leukemia Research. 35(8). 1014–1019. 48 indexed citations

12.

Pons, Aina, Benet Nomdedeu, Alfons Navarro, et al.. (2009). Hematopoiesis-related microRNA expression in myelodysplastic syndromes. Leukemia & lymphoma. 50(11). 1854–1859. 79 indexed citations

13.

Soler-González, Jorge, et al.. (2008). Utilización de recursos de atención primaria por parte de inmigrantes y autóctonos que han contactado con los servicios asistenciales de la ciudad de Lleida. Atención Primaria. 40(5). 225–231. 22 indexed citations

14.

Brodsky, Robert A., Neal S. Young, Elisabetta Antonioli, et al.. (2007). Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood. 111(4). 1840–1847. 457 indexed citations

15.

Talarn, Carme, Álvaro Urbano-Ispizúa, Rodrigo Martino, et al.. (2007). Kinetics of recovery of dendritic cell subsets after reduced-intensity conditioning allogeneic stem cell transplantation and clinical outcome. Haematologica. 92(12). 1655–1663. 14 indexed citations

16.

Granell, Miquel, Álvaro Urbano-Ispizúa, Juan I. Aróstegui, et al.. (2006). Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantation.. PubMed. 91(10). 1372–6. 51 indexed citations

17.

Mercadal, Santiago, Antonio Martı́nez, Benet Nomdedeu, et al.. (2006). Herpes simplex and Epstein‐Barr virus lymphadenitis in a patient with chronic lymphocytic leukemia treated with fludarabine. European Journal Of Haematology. 77(5). 442–444. 10 indexed citations

18.

Granell, Miquel, Álvaro Urbano-Ispizúa, B. Suárez, et al.. (2006). Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation. Experimental Hematology. 34(10). 1435–1441. 70 indexed citations

19.

Jiménez, Mónica, Carmen Martı́nez, Guadalupe Ercilla, et al.. (2005). Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantation. Experimental Hematology. 33(10). 1240–1248. 33 indexed citations

20.

Sacanella, Emilio, Ramón Estruch, Anna Gayà, et al.. (1998). Activated Lymphocytes (CD25⁺ CD69⁺ Cells) and Decreased CD19⁺ Cells in Well‐Nourished Chronic Alcoholics without Ethanol‐Related Diseases. Alcoholism Clinical and Experimental Research. 22(4). 897–901. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact